We are live on ! Find out more
BOCH

Blue Owl Capital Holdings Portfolio holdings

AUM $372M
1-Year Est. Return 78.25%
This Fund
S&P 500
This Quarter Est. Return
+12.37%
1 Year Est. Return
+78.25%
3 Year Est. Return
+112.77%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$310M
AUM Growth
-$220K
Cap. Flow
-$11.6M
Cap. Flow %
-3.74%
Top 10 Hldgs %
66.11%
Holding
86
New
13
Increased
6
Reduced
14
Closed
14

Top Buys

Rank Stock Value
1
TEM
Tempus AI
TEM
+$4.6M
2
RARE icon
Ultragenyx Pharmaceutical
RARE
+$3.68M
3
FLD
Fold Holdings
FLD
+$3.68M
4
STWD icon
Starwood Property Trust
STWD
+$2.55M
5
BMEA icon
Biomea Fusion
BMEA
+$2.5M

Top Sells

Rank Stock Value
1
TQQQ icon
ProShares UltraPro QQQ
TQQQ
+$10M
2
CMPS
Compass Pathways
CMPS
+$3.41M
3
ETWO
E2open Parent Holdings
ETWO
+$3.3M
4
TNGX icon
Tango Therapeutics
TNGX
+$3.23M
5
CNDT icon
Conduent
CNDT
+$2.91M

Sector Composition

Rank Sector Weight
1 Healthcare 51.14%
2 Financials 31.24%
3 Technology 10.9%
4 Consumer Discretionary 5.02%
5 Real Estate 0.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BNAIW
51
Brand Engagement Network Warrant
BNAIW
$1.97M
$50.2K 0.02%
1,666,808
– –
BGLWW
52
Blue Gold Ltd Warrant
BGLWW
$736K
$33.3K 0.01%
+175,000
New +$33.8K
AEON icon
53
AEON Biopharma
AEON
$13.5M
$32.2K 0.01%
42,353
– –
ENGNW icon
54
enGene Therapeutics Warrants
ENGNW
$29.6K 0.01%
36,100
– –
LVWR.WS icon
55
LiveWire Group Warrants
LVWR.WS
$5.09M
$20.4K 0.01%
400,000
– –
DAICW
56
CID HoldCo Inc Warrants
DAICW
$78.4K
$20.1K 0.01%
+300,000
New +$35K
BTMWW
57
DELISTED
Bitcoin Depot Inc Warrant
BTMWW
$19.9K 0.01%
50,000
– –
ZEOWW
58
Zeo Energy Corp Warrants
ZEOWW
$15.7K 0.01%
250,000
– –
TVGNW icon
59
Tevogen Inc. Warrant
TVGNW
$976K
$14K ﹤0.01%
200,000
– –
LIMNW
60
Liminatus Pharma Warrants
LIMNW
$12K ﹤0.01%
+50,000
New +$9.82K
RDZNW icon
61
Roadzen Inc Warrants
RDZNW
$8.64M
$11.5K ﹤0.01%
225,000
– –
NVNIW
62
Nvni Group Limited Warrants
NVNIW
$836K
$10.3K ﹤0.01%
200,000
– –
PGYWW
63
Pagaya Technologies Ltd Warrants
PGYWW
$1.38M
$8.15K ﹤0.01%
48,661
– –
BDMDW
64
Baird Medical Investment Holdings Warrant
BDMDW
$8.01K ﹤0.01%
100,000
– –
KPLT icon
65
Katapult Holdings
KPLT
$33.2M
$6.51K ﹤0.01%
+5,421
New +$44.4K
CEROW
66
DELISTED
CERo Therapeutics Warrants
CEROW
$5.35K ﹤0.01%
224,930
– –
BSLKW
67
DELISTED
Bolt Projects Holdings Warrant
BSLKW
$4.32K ﹤0.01%
166,666
– –
WALDW icon
68
Waldencast PLC Warrant
WALDW
$4.21M
$3.23K ﹤0.01%
33,333
– –
KPLTW
69
DELISTED
Katapult Holdings Warrant
KPLTW
$3.2K ﹤0.01%
400,000
– –
ASBPW
70
Aspire Biopharma Warrant
ASBPW
$2.23K ﹤0.01%
50,000
– –
XBPEW
71
XBP Europe Holdings Warrant
XBPEW
$1.35K ﹤0.01%
24,778
– –
SDSTW
72
Stardust Power Inc Warrant
SDSTW
$447 ﹤0.01%
16,666
– –
ETWO
73
DELISTED
E2open Parent Holdings
ETWO
– –
-1,650,943
Closed -$3.3M
GOCO
74
DELISTED
GoHealth
GOCO
– –
-25,096
Closed -$694K
INZY
75
DELISTED
Inozyme Pharma
INZY
– –
-1,080,027
Closed -$983K
1 2
3
4

Similar funds

PC
Promethos Capital Boston, Massachusetts $372M AUM 23.19% 1-Year Est. Return
GIP
Gavilan Investment Partners Burlingame, California $372M AUM 6.04% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
SAAM
Solus Alternative Asset Management Summit, New Jersey $372M AUM 45.33% 1-Year Est. Return
KP
Kiltearn Partners Edinburgh, United Kingdom $372M AUM 18.16% 1-Year Est. Return
TCM
Thomist Capital Management Houston, Texas $371M AUM 77.62% 1-Year Est. Return
PAA
Peregrine Asset Advisers Portland, Oregon $371M AUM 41.36% 1-Year Est. Return
JC
Joho Capital New York $373M AUM 18.89% 1-Year Est. Return

Blue Owl Capital Holdings's Q2 2025 Portfolio in Review

As of Q2 2025, Blue Owl Capital Holdings held 86 positions worth $310M, down 0.07% from $310M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Blue Owl Capital Holdings withdrew a net $11.6M in Q2 2025, closing 14 positions and reducing 14 holdings. Its most notable exit was ProShares UltraPro QQQ, an estimated $10M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 44% a quarter earlier, followed by Financials and Technology.

Against the trend, Blue Owl Capital Holdings opened a new position in Tempus AI worth $5.09M.

  • Blue Owl Capital Holdings's largest Q2 2025 buy was Tempus AI: 80,167 shares worth $5.09M.
  • Blue Owl Capital Holdings added most to Ultragenyx Pharmaceutical in Q2 2025, an estimated $3.68M increase.
  • Blue Owl Capital Holdings's biggest Q2 2025 reduction was Compass Pathways, cutting an estimated $3.41M.
  • Blue Owl Capital Holdings fully exited ProShares UltraPro QQQ in Q2 2025, selling an estimated $10M.
  • Blue Owl Capital Holdings's ten largest holdings make up 66% of its $310M portfolio in Q2 2025.
  • Blue Owl Capital Holdings opened 13 new positions and closed 14 in Q2 2025.
  • Blue Owl Capital Holdings's portfolio value fell 0.07% quarter-over-quarter to $310M.

Based on Blue Owl Capital Holdings's 13F filing for Q2 2025, filed 11 Aug 2025.